Savara Pharmaceuticals
SVRA
#6474
Rank
ยฃ0.45 B
Marketcap
ยฃ2.67
Share price
3.70%
Change (1 day)
-8.14%
Change (1 year)

Savara Pharmaceuticals (SVRA) - Cash on Hand

Cash on Hand as of June 2024 : ยฃ96.55 Million

According to Savara Pharmaceuticals's latest financial reports the company has ยฃ96.55 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Savara Pharmaceuticals - Cash on Hand chart (from 2002 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31ยฃ0.12 B22.45%
2022-12-31ยฃ0.10 B-12.86%
2021-12-31ยฃ0.11 B98.02%
2020-12-31ยฃ60.29 M-35.06%
2019-12-31ยฃ92.85 M6.35%
2018-12-31ยฃ87.31 M25.12%
2017-12-31ยฃ69.78 M543.88%
2016-12-31ยฃ10.83 M-60.81%
2015-12-31ยฃ27.65 M-24.85%
2014-12-31ยฃ36.79 M36.73%
2013-12-31ยฃ26.91 M19.14%
2012-12-31ยฃ22.58 M-30.75%
2011-12-31ยฃ32.62 M79.99%
2010-12-31ยฃ18.12 M238.38%
2009-12-31ยฃ5.35 M-20.3%
2008-12-31ยฃ6.72 M-60.1%
2007-12-31ยฃ16.84 M-36.24%
2006-12-31ยฃ26.41 M101.64%
2005-12-31ยฃ13.1 M93%
2004-12-31ยฃ6.78 M187.32%
2003-12-31ยฃ2.36 M3545.14%
2002-12-31ยฃ0.06 M-42.86%
2001-12-31ยฃ0.11 M-88.59%
2000-12-31ยฃ0.99 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ13.02 M-86.51%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ32.24 M-66.61%๐Ÿ‡บ๐Ÿ‡ธ USA